🔎 Trials Near Me

Почетна › Рак простате › Džordžija

Kliničke studije za Рак простате u državi Džordžija

44 studija za Рак простате traži učesnike na lokacijama u državi Džordžija.

Gradovi u državi Džordžija

Zvanični tekst studije (na engleskom)

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

  • Emory University, Atlanta
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 12. 11. 2026. · NCT04221542

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03866382

WATER IV PCa (AS Sub-study)

  • Georgia Urology, Atlanta
Тражи се учесник
Узраст 45 и старији · Мушкарци · Ажурирано 6. 11. 2026. · NCT07650448

Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

  • Emory University, Atlanta
Тражи се учесникФаза 4
Узраст 18 и старији · Мушкарци · Ажурирано 5. 11. 2026. · NCT07569926

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • Emory University, Atlanta
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06465069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Northeast Georgia Medical Center Braselton, Braselton
  • Atlanta VA Medical Center, Decatur
  • Northeast Georgia Medical Center-Gainesville, Gainesville
  • и још 4
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • Emory University School of Medicine - Winship Cancer Institute, Atlanta
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07114601

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

  • Emory University Winship Cancer Institute, Atlanta
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 3. 11. 2026. · NCT06095089

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

  • CTCA at Southeastern Regional Medical Center, Newnan
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 3. 11. 2026. · NCT07200830

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • Northside Hospital, Atlanta
  • Northside Hospital - Duluth, Duluth
  • Northside Hospital - Gwinnett, Lawrenceville
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 3. 11. 2026. · NCT06931340

CT- Versus MRI-Based Planning for High-Dose-Rate Prostate Brachytherapy for Prostate Cancer

  • Emory Proton Therapy Center, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
Тражи се учесник
Узраст 18 и старији · Мушкарци · Ажурирано 2. 11. 2026. · NCT07859722

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  • Emory University School of Medicine- Grady Campus ( Site 0103), Atlanta
  • Winship Cancer Institute, Emory University ( Site 0003), Atlanta
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 30. 10. 2026. · NCT06925737

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

  • Emory University, Atlanta
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT07288359

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • Grady Health System, Atlanta
  • Emory Proton Therapy Center, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • и још 3
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 23. 10. 2026. · NCT05946213

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

  • Research Site 114, Atlanta
  • Research Site 139, Atlanta
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT05914116

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  • Northside Hospital-Northside Hospital Oncology Network ( Site 0100), Atlanta
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06136650

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • Emory University - Winship Cancer Institute, Atlanta
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06582017

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  • City of Hope Atlanta, Newnan
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 20. 10. 2026. · NCT07213674

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

  • University Cancer and Blood Center LLC, Athens
Тражи се учесникФаза 3
Узраст од 18 до 100 · Мушкарци · Ажурирано 15. 10. 2026. · NCT06855277

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

  • Research Site, Newnan
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 14. 10. 2026. · NCT06952803

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  • Tennessee Oncology, PLLC - Dalton, Dalton
  • Tennessee Oncology, PLLC - Ringgold, Ringgold
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 14. 10. 2026. · NCT07028853

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • Grady Health System, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • и још 3
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 8. 10. 2026. · NCT03678025

Addressing Health Literacy With a Tailored Survivorship Care Plan

  • Grady Memorial Hospital, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • Atlanta VA Medical Center, Atlanta
Тражи се учесник
Узраст 18 и старији · Мушкарци · Ажурирано 30. 9. 2026. · NCT06674863

Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial

  • Augusta University Research Institute, Augusta
Тражи се учесник
Узраст 18 и старији · Мушкарци · Ажурирано 28. 9. 2026. · NCT06496256

A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

  • Emory Winship Cancer Institute, Atlanta
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 24. 9. 2026. · NCT07543055

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

  • University Cancer and Blood Center LLC, Athens
  • Emory University, Atlanta
Тражи се учесникФаза 2/3
Узраст од 18 до 100 · Мушкарци · Ажурирано 22. 9. 2026. · NCT06780670

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

  • Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 17. 9. 2026. · NCT05011383

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

  • Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 17. 9. 2026. · NCT04038502

Prostate Active Surveillance Study

  • Emory University, Atlanta
Тражи се учесникОпсервациона студија
Узраст 21 и старији · Мушкарци · Ажурирано 2. 9. 2026. · NCT00756665

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

  • Emory University Hospital, Atlanta
Тражи се учесникФаза 1/2
Узраст 18 и старији · Мушкарци · Ажурирано 20. 8. 2026. · NCT06785636

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  • Winship Cancer Institute, Emory University, Atlanta
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 17. 8. 2026. · NCT06842498

An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique

  • Emory University Hospital, Atlanta
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 14. 7. 2026. · NCT06865768

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Grady Health System, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • и још 4
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 14. 7. 2026. · NCT06592924

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

  • University Cancer and Blood Center LLC, Athens
Тражи се учесникФаза 4
Узраст од 18 до 100 · Мушкарци · Ажурирано 4. 6. 2026. · NCT05803941

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

  • Morehouse School of Medicine, Atlanta
  • Emory Winship Cancer Institute, Atlanta
Тражи се учесникОпсервациона студија
Узраст 21 и старији · Мушкарци · Ажурирано 22. 5. 2026. · NCT03151629

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

  • Emory University Hospital, Atlanta
Тражи се учесникФаза 1/2
Узраст 18 и старији · Мушкарци · Ажурирано 14. 5. 2026. · NCT05413850

Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors

  • Georgia College & State University, Milledgeville
Тражи се учесник
Узраст 18 и старији · Мушкарци · Ажурирано 1. 4. 2026. · NCT06651359

T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer

  • Emory University, Atlanta
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 4. 3. 2026. · NCT05586360

REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial

  • Emory Proton Therapy Center, Atlanta
  • Winship at Emory Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 24. 2. 2026. · NCT06650579

Study of AZD0754 in Participants With Metastatic Prostate Cancer

  • Research Site, Atlanta
Тражи се учесникФаза 1/2
Узраст од 18 до 130 · Мушкарци · Ажурирано 23. 2. 2026. · NCT06267729

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.